Moderna, Inc. (MRNA) 股价在盘前交易中强势上涨3.7%,此前该公司宣布已达成协议,将支付最高22.5亿美元,以了结与其新冠疫苗相关的专利纠纷。这一重大和解协议消除了笼罩在该公司头顶的一大不确定性,为市场注入了积极情绪。
Moderna, Inc. (MRNA) 股价在盘前交易中强势上涨3.7%,此前该公司宣布已达成协议,将支付最高22.5亿美元,以了结与其新冠疫苗相关的专利纠纷。这一重大和解协议消除了笼罩在该公司头顶的一大不确定性,为市场注入了积极情绪。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.